REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT

用于临床前发现、评估和开发的化学品和药物的注册、储存和分配

• 批准号: 10797066
• 负责人: RICHARD SCHROCK
• 金额: $ 325.38万
• 依托单位: FISHER BIOSERVICES, INC.
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-01 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10797066
• 关键词: Biological; Chemicals; Contracts; Databases; Development; Equipment and supply inventories; Evaluation; Extramural Activities; Goals; National Cancer Institute; Natural Products; Pharmaceutical Preparations; Preclinical Drug Evaluation; Program Evaluation; Research; Research Personnel; Sampling; Screening for cancer; Shipping; Therapeutic Agents; Update; anti-cancer; chemotherapeutic agent; pre-clinical; repository; small molecule; small molecule therapeutics

The purpose of this contract is to operate and maintain the National Cancer Institute's Chemotherapeutic Agents Repository (NCI-CAR). The principal goals of this contract are 1) to support compound acquisition activities related to the DTP anticancer pre-clinical drug evaluation program which seeks to identify new small molecule therapeutic agents and 2) distribution of chemicals to intramural and extramural investigators for research purposes. The primary tasks of the contract are the receipt, registration, storage, analysis, arraying and distribution of small molecules and purified natural products that will be evaluated in DTP anti-cancer screens, and also distributed to extramural researchers.

该合同的目的是操作和维护国家癌症研究所的化学治疗剂 存储库（NCI-CAR）。本合同的主要目标是1）支持复合收购活动相关 旨在识别新的小分子治疗的DTP抗癌前药物评估计划 代理和2）用于研究目的的化学物质分配给壁内和壁外研究者。合同的主要任务是将在DTP抗癌筛查中评估的小分子和纯天然产物的收据，存储，分析，阵列和分布，还将分配给神经外研究人员。